The VAccine cLinical study reporting gUidEline: the VALUE checklist with explanation and elaboration. [PDF]
Duan Y +10 more
europepmc +1 more source
IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner. [PDF]
Yoshioka Y +19 more
europepmc +1 more source
Reactogenicity of hexavalent vaccines modelled in Swedish birth cohorts
George Marina +2 more
openaire +3 more sources
Risk Factors Associated with Adverse Events Following COVID-19 Vaccination in Children Aged 5-11 Years: A Real-World Observational Study. [PDF]
Rivas Paterna MÁ +5 more
europepmc +1 more source
From pathogen defence to precision health infrastructure: mRNA vaccines beyond infectious disease in preventive health, chronic disease management, and population wellbeing. [PDF]
Ugwu OP, Ugwu CN, Anyanwu GE, Basajja M.
europepmc +1 more source
Extended dosing intervals enhance the durability of a self-amplifying mRNA vaccine against pandemic H5N1 influenza: a randomized, observer-blind, dose-finding Phase I study. [PDF]
Pragalos AA +9 more
europepmc +1 more source
An old foe comes swooping back: Whooping cough resurgence-Okay, now what? [PDF]
Musgrave DL, Creech CB.
europepmc +1 more source
Safety of the Dengue Vaccine TAK-003 and Factors Associated with Adverse Events in Travellers from Non-Endemic Areas: A Real-World Prospective Multicentre Pharmacovigilance Cohort Study in Spain. [PDF]
Camprubí-Ferrer D +25 more
europepmc +1 more source
Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial. [PDF]
Shinde V +11 more
europepmc +1 more source
A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea. [PDF]
Choi WS +12 more
europepmc +1 more source

